New Bolton Center Kennett Square, PA
Emergencies & Appointments:
Ryan Hospital Philadelphia, PA

MICHAEL J. MAY, B. Sc., M.Sc., Ph.D.

Associate Professor, Department of Biomedical Sciences, University of Pennsylvania School of Veterinary Medicine

Research Areas: Inflammatory diseases, Inflammatory responses, Cancer, NF-Kappa B activation, Signal transduction, Chronic inflammatory diseases
PubMed Link
Contact Information:
Department of Biomedical Sciences (OVH 200E),
The School of Veterinary Medicine,
The University of Pennsylvania
3800 Spruce Street, Philadelphia PA 19104.

The May laboratory investigates signal transduction pathways that lead to altered patterns of gene expression in immune and inflammatory responses. We are particularly interested in understanding how the loss of control of normal signaling contributes to the progression of diseases such as chronic inflammation and cancer. Our goal is to determine the specific molecular events underlying aberrant signals and to define realistic targets for selectively blocking abnormal, while maintaining physiologically normal responses. The focus of our work is the Nuclear Factor (NF)-kappa B transcription factor activation pathway that is critical for inflammation, innate and adaptive immunity and lymphocyte development. NF-kappa B activation is typically a rapid and transient response, however constitutive NF- kappa B activity occurs at sites of chronic inflammation and in various tumors, leukemias and lymphomas. We combine cellular, molecular and genetic approaches to determine the mechanisms that redirect normal NF-kappa B activation pathways into this functionally abnormal, constitutively active state. In addition to determining the basic mechanisms of NF-kappa B activation we have a long-standing interest in understanding the role of NF-kappa B in regulating the phenotype and function of vascular endothelial cells.

A second related interest is to explore the experimental and therapeutic potential of peptide transduction technology as a strategy for modulating specific cell signaling responses. We previously described a small cell-permeable peptide inhibitor of NF-kappa B activity and demonstrated the feasibility of this approach both in vitro and in vivo. We will continue to exploit this exciting novel strategy to fully dissect deregulated NF-kappa B activity in chronic inflammatory diseases.

Currently our active areas of research are:

1. Determining the biochemical and molecular mechanisms that regulate the activity of the I Kappa B Kinase complex.
2. Investigating the signals that regulate vascular endothelial cell function in immune and inflammatory responses.
3. Developing novel targets for cell-permeable peptide inhibitors of NF-kappa B.

Berry Corbett T, May Michael J, Freedman Bruce D STIM- and Orai-mediated calcium entry controls NF-?B activity and function in lymphocytes. [PMID 30048879] Cell calcium 74: 131-143, 2018.

Liu Xiaohong, Berry Corbett T, Ruthel Gordon, Madara Jonathan J, MacGillivray Katelyn, Gray Carolyn M, Madge Lisa A, McCorkell Kelly A, Beiting Daniel P, Hershberg Uri, May Michael J, Freedman Bruce D T Cell Receptor-induced Nuclear Factor ?B (NF-?B) Signaling and Transcriptional Activation Are Regulated by STIM1- and Orai1-mediated Calcium Entry. [PMID 26826124] The Journal of biological chemistry 291: 8440-52, 2016.

McCorkell Kelly A, May Michael J Noncanonical NF-?B activation and SDF-1 expression in human endothelial cells. [PMID 25736748] Methods in molecular biology (Clifton, N.J.) 1280: 155-80, 2015.

Gray Carolyn M, May Michael J Stable reconstitution of IKK-deficient mouse embryonic fibroblasts. [PMID 25736749] Methods in molecular biology (Clifton, N.J.) 1280: 181-95, 2015.

McCorkell Kelly A, May Michael J NEMO-binding domain peptide inhibition of inflammatory signal-induced NF-?B activation in vivo.NEMO-binding domain peptide inhibition of inflammatory signal-induced NF-?B activation in vivo. [PMID 25736769] Methods in molecular biology (Clifton, N.J.) 1280: 505-25, 2015.

Ager Ann, May Michael J Understanding high endothelial venules: Lessons for cancer immunology. [PMID 26155419] Oncoimmunology 4: e1008791, 2015.

Giacomin Paul R, Moy Ryan H, Noti Mario, Osborne Lisa C, Siracusa Mark C, Alenghat Theresa, Liu Bigang, McCorkell Kelly A, Troy Amy E, Rak Gregory D, Hu Yinling, May Michael J, Ma Hak-Ling, Fouser Lynette A, Sonnenberg Gregory F, Artis David Epithelial-intrinsic IKKa expression regulates group 3 innate lymphoid cell responses and antibacterial immunity.[PMID 26371187] The Journal of experimental medicine 212: 1513-28, 2015.

Gray Carolyn M, Remouchamps Caroline, McCorkell Kelly A, Solt Laura A, Dejardin Emmanuel, Orange Jordan S, May Michael J Noncanonical NF-?B Signaling Is Limited by Classical NF-?B Activity. [PMID 24497610] Science Signaling 7: ra13, 2014.

Bhattacharya Sabyasachi, Katlinski Kanstantsin V, Reichert Maximilian, Takano Shigetsugu, Brice Angela, Zhao Bin, Yu Qiujing, Zheng Hui, Carbone Christopher J, Katlinskaya Yuliya V, Leu N Adrian, McCorkell Kelly A, Srinivasan Satish, Girondo Melanie, Rui Hallgeir, May Michael J, Avadhani Narayan G, Rustgi Anil K, Fuchs Serge Y Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury.[PMID 24480543] EMBO molecular medicine 6: 384-97, 2014.

Habineza Ndikuyeze Georges, Gaurnier-Hausser Anita, Patel Reema, Baldwin Albert S, May Michael J, Flood Patrick, Krick Erika, Propert Kathleen J, Mason Nicola J A phase I clinical trial of systemically delivered NEMO binding domain peptide in dogs with spontaneous activated B-cell like diffuse large B-cell lymphoma. [PMID 24798348] PloS one 9: e95404, 2014.

Gray Carolyn M, McCorkell Kelly A, Chunduru Srinivas K, McKinlay Mark A, May Michael J Negative feedback regulation of NF-?B-inducing kinase is proteasome-dependent but does not require cellular inhibitors of apoptosis. [PMID 24942881] Biochemical and biophysical research communications 450: 341-6, 2014.

Sehnert B, Burkhardt H, Wessels J T, Schröder Ag, May M J, Vestweber D, Zwerina J, Warnatz K, Nimmerjahn F, Schett G, Dübel S, Voll R E NF-?B inhibitor targeted to activated endothelium demonstrates a critical role of endothelial NF-?B in immune-mediated diseases. [PMID 24062461] Proceedings of the National Academy of Sciences of the United States of America 110: 16556-61, 2013.

Pringle L M, Young R, Quick L, Riquelme D N, Oliveira A M, May M J, Chou M M Atypical mechanism of NF-?B activation by TRE17/ubiquitin-specific protease 6 (USP6) oncogene and its requirement in tumorigenesis. [PMID 22081069] Oncogene 31: 3525-35, 2012.

Whitmarsh Ryan J, Gray Carolyn M, Gregg Beth, Christian David A, May Michael J, Murray Peter J, Hunter Christopher A A critical role for SOCS3 in innate resistance to Toxoplasma gondii.[PMID 21925110] Cell host & microbe 10: 224-36, 2011.

May Michael J IL-17R signaling: new players get in on the Act1. [PMID 21852777] Nature immunology 12: 813-5, 2011.

Irrinki Krishna M, Mallilankaraman Karthik, Thapa Roshan J, Chandramoorthy Harish C, Smith Frank J, Jog Neelakshi R, Gandhirajan Rajesh Kumar, Kelsen Steven G, Houser Steven R, May Michael J, Balachandran Siddharth, Madesh Muniswamy Requirement of FADD, NEMO, and BAX/BAK for aberrant mitochondrial function in tumor necrosis factor alpha-induced necrosis.[PMID 21746883] Molecular and cellular biology 31: 3745-58, 2011.

Gaurnier-Hausser Anita, Patel Reema, Baldwin Albert S, May Michael J, Mason Nicola J NEMO-binding domain peptide inhibits constitutive NF-?B activity and reduces tumor burden in a canine model of relapsed, refractory diffuse large B-cell lymphoma.[PMID 21610150] Clinical cancer research : an official journal of the American Association for Cancer Research 17: 4661-71, 2011.

Madge Lisa A, May Michael J The NF?B paradox: RelB induces and inhibits gene expression.[PMID 21191180] Cell cycle (Georgetown, Tex.) 10: 6-7, 2011.

Neely R J, Brose M S, Gray C M, McCorkell K A, Leibowitz J M, Ma C, Rothstein J L & May M J The RET/PTC3 oncogene activates classical NF-kappaB by stabilizing NIK. [PMID 20818435] Oncogene 6: 87-96, 2011.

Yatherajam G, Banerjee PP, McCorkell KA, Solt LA, Hanson EP, Madge LA, Kang S, Worley PF, Orange JS & May MJ. Cutting edge: association with I kappa B kinase beta regulates the subcellular localization of Homer3. [PMID 20693425] Journal of immunology 185: 2665-9, 2010.

Madge LA & May MJ Classical NF-kappaB activation negatively regulates non-canonical NF-kappaB-dependent CXCL12 expression.[PMID 20923761] The Journal of biological chemistry 285 : 38069-077, 2010.

Solt LA, Madge LA & May MJ NEMO-binding domains of both IKKalpha and IKKbeta regulate IkappaB kinase complex assembly and classical NF-kappaB activation.[PMID 19666475] The Journal of biological chemistry 284: 27596-608, 2009.

Wharry CE, Haines KM, Carroll RG & May MJ. Constitutive non-canonical NFkappaB signaling in pancreatic cancer cells. [PMID 19502791] Cancer biology & therapy 8: 1567-76, 2009.

Madge, Lisa A. May, Michael J. Inhibiting proinflammatory NF-kappaB signaling using cell-penetrating NEMO binding domain peptides. [PMID 19347279] Methods in Molecular Biology 512: 209-32, 2009.

Solt, Laura A. May, Michael J. The IkappaB kinase complex: master regulator of NF-kappaB signaling. [PMID 18626576] Immunologic Research 42: 3-18, 2008.

Hanson, Eric P. Monaco-Shawver, Linda. Solt, Laura A. Madge, Lisa A. Banerjee, Pinaki P. May, Michael J. Orange, Jordan S. Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. [PMID 18851874] Journal of Allergy & Clinical Immunology 122: 1169-1177.e16, 2008.

Orange, J S. May, M J. Cell penetrating peptide inhibitors of nuclear factor-kappa B. [Review] [202 refs] [PMID 18668204] Cellular & Molecular Life Sciences 65: 3564-91, 2008.

Bredemeyer, Andrea L. Helmink, Beth A. Innes, Cynthia L. Calderon, Boris. McGinnis, Lisa M. Mahowald, Grace K. Gapud, Eric J. Walker, Laura M. Collins, Jennifer B. Weaver, Brian K. Mandik-Nayak, Laura. Schreiber, Robert D. Allen, Paul M. May, Michael J. Paules, Richard S. Bassing, Craig H. Sleckman, Barry P. DNA double-strand breaks activate a multi-functional genetic program in developing lymphocytes. [PMID 18849970] Nature 456: 819-23, 2008.

Wharry, Catherine E. May, Michael J. Raising the price of platinum: inhibition of NFkappaB in human tumor epithelial cells.[PMID 18953187] Cancer Biology & Therapy 7: 1415-7, 2008.

Nijboer, Cora H. Heijnen, Cobi J. Groenendaal, Floris. May, Michael J. van Bel, Frank. Kavelaars, Annemieke. A dual role of the NF-kappaB pathway in neonatal hypoxic-ischemic brain damage.[PMID 18420947] Stroke 39: 2578-86, 2008.

Nijboer, Cora H A. Heijnen, Cobi J. Groenendaal, Floris. May, Michael J. van Bel, Frank. Kavelaars, Annemieke. Strong neuroprotection by inhibition of NF-kappaB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines.[PMID 18420952] Stroke 39: 2129-37, 2008.

Madge LA, Kluger MS, Orange JS & May MJ. Lymphotoxin-alpha 1 beta 2 and LIGHT induce classical and noncanonical NF-kappa B-dependent proinflammatory gene expression in vascular endothelial cells. [PMID 18292573] Journal of Immunology 180: 3467-77, 2008.

Huang, Guo N. Huso, David L. Bouyain, Samuel. Tu, Jianchen. McCorkell, Kelly A. May, Michael J. Zhu, Yuwen. Lutz, Michael. Collins, Samuel. Dehoff, Marlin. Kang, Shin. Whartenby, Katharine. Powell, Jonathan. Leahy, Daniel. Worley, Paul F. NFAT binding and regulation of T cell activation by the cytoplasmic scaffolding Homer proteins. [PMID 18218901] Science 319: 476-81, 2008.

B. Sc. (Department of Immunology) University of Glasgow, UK, 1988

M.Sc. (Department of Immunology) University of Manchester, UK, 1992

Ph.D. (Vascular Biology Research Centre) King’s College London, UK. , 1996

Howard Hughes Medical Institute Immunobiology Section Yale University Medical School (1996 to 1998)
Postdoctoral Research Associate

Irvington Institute for Immunological Research Immunobiology Section Yale University Medical School (1998 to 2000)
Postdoctoral Fellow